California Public Employees Retirement System Xenon Pharmaceuticals Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$16.81 - $20.0 $1.17 Million - $1.4 Million	-69,800 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$9.49 - $16.04 $75,806 - $128,127	-7,988 Reduced 10.27%	69,800 $1.07 Million
Q3 2020 Nov 05, 2020	SELL	$10.82 - $13.35 $3,451 - $4,258	-319 Reduced 0.41%	77,788 $861,000
Q2 2020 Aug 12, 2020	BUY	$10.21 - $14.9 $288,452 - $420,954	28,252 Added 56.67%	78,107 $979,000
Q1 2020 May 12, 2020	SELL	$8.08 - $17.57 $70,296 - $152,859	-8,700 Reduced 14.86%	49,855 $565,000
Q4 2019 Jan 27, 2020	SELL	$8.11 - $14.65 $30,006 - $54,205	-3,700 Reduced 5.94%	58,555 $768,000
Q3 2019 Oct 31, 2019	BUY	$8.74 - $10.51 $53,751 - $64,636	6,150 Added 10.96%	62,255 $561,000
Q2 2019 Aug 15, 2019	BUY	$8.51 - $10.75 $9,403 - $11,878	1,105 Added 2.01%	56,105 $553,000
Q3 2017 Nov 15, 2017	BUY	$2.45 - $3.25 $134,750 - $178,750	55,000	55,000 $162,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

Avoro Capital Advisors LLC New York, NY

5.67M
Shares

$217 Million
3.36% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.6M
Shares

$176 Million
1.77% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$147 Million
0.03% of portfolio
Braidwell LP Stamford, CT

2.71M
Shares

$104 Million
3.02% of portfolio
Commodore Capital LP New York, NY

2.7M
Shares

$103 Million
9.03% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account